|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/26/19 Aphria Inc. 40-F/A 5/31/19 145:20M CNW Group Ltd/FA |
Document/Exhibit Description Pages Size
1: 40-F/A Amendment to Registration Statement or Annual HTML 51K
Report by a Canadian Issuer
8: R1 Document and Entity Information HTML 57K
9: R2 Consolidated Statements of Financial Position HTML 134K
10: R3 Consolidated Statements of Income and HTML 128K
Comprehensive Income
11: R4 Consolidated Statements of Changes in Equity HTML 108K
12: R5 Consolidated Statements of Cash Flows HTML 137K
13: R6 Consolidated Statements of Cash Flows HTML 42K
(Parenthetical)
14: R7 Nature of operations HTML 41K
15: R8 Basis of preparation HTML 132K
16: R9 Significant accounting policies HTML 146K
17: R10 Marketable securities HTML 122K
18: R11 Prepaids and other current assets HTML 56K
19: R12 Inventory HTML 86K
20: R13 Biological assets HTML 64K
21: R14 Related party transactions HTML 59K
22: R15 Capital assets HTML 212K
23: R16 Intangible Assets HTML 196K
24: R17 Business Acquisitions HTML 487K
25: R18 Convertible notes receivable HTML 72K
26: R19 Interest in equity investees HTML 110K
27: R20 Long-term investments HTML 348K
28: R21 Promissory notes receivable HTML 84K
29: R22 Income taxes and deferred income taxes HTML 127K
30: R23 Bank indebtedness HTML 37K
31: R24 Promissory note payable HTML 60K
32: R25 Long-term debt HTML 102K
33: R26 Convertible debentures HTML 60K
34: R27 Share capital HTML 71K
35: R28 Warrants HTML 92K
36: R29 Stock options HTML 212K
37: R30 Non-controlling interest HTML 263K
38: R31 General and administrative expenses HTML 67K
39: R32 Share-based compensation HTML 64K
40: R33 Non-operating income (Loss) HTML 84K
41: R34 Gain on long-term investments HTML 154K
42: R35 Earnings (loss) per share HTML 76K
43: R36 Change in non-cash working capital HTML 64K
44: R37 Financial risk management and financial HTML 182K
instruments
45: R38 Commitments and contingencies HTML 54K
46: R39 Segment reporting HTML 132K
47: R40 Subsequent events HTML 37K
48: R41 Significant accounting policies (Policies) HTML 183K
49: R42 Basis of preparation (Tables) HTML 117K
50: R43 Significant accounting policies (Tables) HTML 83K
51: R44 Marketable securities (Tables) HTML 120K
52: R45 Prepaids and other current assets (Tables) HTML 56K
53: R46 Inventory (Tables) HTML 84K
54: R47 Biological assets (Tables) HTML 55K
55: R48 Related party transactions (Tables) HTML 54K
56: R49 Capital assets (Tables) HTML 212K
57: R50 Intangible assets (Tables) HTML 196K
58: R51 Business Acquisitions (Tables) HTML 484K
59: R52 Convertible notes receivable (Tables) HTML 63K
60: R53 Interest in equity investees (Tables) HTML 100K
61: R54 Long-term investments (Tables) HTML 325K
62: R55 Promissory notes receivable (Tables) HTML 83K
63: R56 Income taxes and deferred income taxes (Tables) HTML 128K
64: R57 Promissory notes payable (Tables) HTML 59K
65: R58 Long-term debt (Tables) HTML 100K
66: R59 Convertible debentures (Tables) HTML 53K
67: R60 Share capital (Tables) HTML 64K
68: R61 Warrants (Tables) HTML 94K
69: R62 Stock options (Tables) HTML 209K
70: R63 Non-controlling interest (Tables) HTML 263K
71: R64 General and administrative expenses (Tables) HTML 66K
72: R65 Share-based compensation (Tables) HTML 62K
73: R66 Non-operating income (Loss) (Tables) HTML 84K
74: R67 Gain on long-term investments (Tables) HTML 153K
75: R68 Earnings (Loss) Per Share (Tables) HTML 75K
76: R69 Change in non-cash working capital (Tables) HTML 63K
77: R70 Financial risk management and financial HTML 173K
instruments (Tables)
78: R71 Commitments and contingencies (Tables) HTML 50K
79: R72 Segment reporting (Tables) HTML 131K
80: R73 Nature of operations (Details) HTML 37K
81: R74 Basis of preparation (Details) HTML 102K
82: R75 Significant accounting policies - Marketable HTML 36K
securities (Details)
83: R76 Significant accounting policies - Capital assets HTML 44K
(Details)
84: R77 Significant accounting policies - Intangible HTML 49K
assets (Details)
85: R78 Marketable securities (Details) HTML 90K
86: R79 Prepaids and other current assets (Details) HTML 45K
87: R80 Inventory (Details) HTML 73K
88: R81 Biological assets - Rollforward (Details) HTML 47K
89: R82 Biological assets - Additional Information HTML 60K
(Details)
90: R83 Biological assets - Sensitivity of the inputs HTML 44K
(Details)
91: R84 Related party transactions (Details) HTML 67K
92: R85 Capital assets (Details) HTML 92K
93: R86 Intangible assets (Details) HTML 95K
94: R87 Business Acquisitions - Acquisition of Broken HTML 108K
Coast Cannabis Ltd. (Details)
95: R88 Business Acquisitions - Acquisition of Nuuvera HTML 142K
Corp. (Details)
96: R89 Business Acquisitions - Acquisition of LATAM HTML 100K
Holdings Inc. (Details)
97: R90 Business Acquisitions - Acquisition of CC Pharma HTML 99K
GmbH (Details)
98: R91 Business Acquisitions - Goodwill (Details) HTML 71K
99: R92 Convertible notes receivable (Details) HTML 110K
100: R93 Interest in equity investees (Details) HTML 41K
101: R94 Interest in equity investees - Liberty Health HTML 55K
Sciences (Details)
102: R95 Interest in equity investees - Obligation HTML 73K
Agreement (Details)
103: R96 Interest in equity investees - Althea (Details) HTML 66K
104: R97 Interest in equity investees - Financial HTML 50K
information (Details)
105: R98 Interest in equity investees - Reconciliation to HTML 49K
Carrying Amount (Details)
106: R99 Long-term investments - Rollforward (Details) HTML 175K
107: R100 Long-term investments - Additional Information HTML 169K
(Details)
108: R101 Long-term investments - US legalization options HTML 82K
and Green Acre Capital Fund I and II (Details)
109: R102 Promissory notes receivable (Details) HTML 63K
110: R103 Income taxes and deferred income taxes - HTML 67K
Reconciliation of Income Taxes at Statutory Rate
(Details)
111: R104 Income taxes and deferred income taxes - HTML 55K
Components of deferred tax (Details)
112: R105 Bank indebtedness (Details) HTML 38K
113: R106 Promissory note payable (Details) HTML 47K
114: R107 Long-term debt (Details) HTML 83K
115: R108 Long-term debt - Repayment (Details) HTML 50K
116: R109 Long-term debt - Additional information (Details) HTML 88K
117: R110 Convertible debentures (Details) HTML 71K
118: R111 Share capital (Details) HTML 97K
119: R112 Warrants - Type Of Warrants (Details) HTML 49K
120: R113 Warrants - Rollforward (Details) HTML 57K
121: R114 Warrants - Additional information (Details) HTML 46K
122: R115 Stock options - Narrative (Details) HTML 47K
123: R116 Stock options - Rollforward (Details) HTML 62K
124: R117 Stock options - Granted and Exercise price range HTML 102K
(Details)
125: R118 Stock options - Outstanding options and fair value HTML 164K
of options (Details)
126: R119 Stock options - Inputs (Details) HTML 51K
127: R120 Non-controlling interest (Details) HTML 107K
128: R121 General and administrative expenses (Details) HTML 52K
129: R122 Share-based compensation (Details) HTML 65K
130: R123 Non-operating income (Loss) (Details) HTML 66K
131: R124 Gain on long-term investments (Details) HTML 91K
132: R125 Earnings (loss) per share - Basic earnings (Loss) HTML 45K
Per Share (Details)
133: R126 Earnings (loss) per share - Diluted earnings per HTML 52K
share (Details)
134: R127 Change in non-cash working capital (Details) HTML 53K
135: R128 Financial risk management and financial HTML 41K
instruments (Details)
136: R129 Financial risk management and financial HTML 62K
instruments - Fair Value hierarchy (Details)
137: R130 Financial risk management and financial HTML 50K
instruments - Statement of changes in the level 3
items (Details)
138: R131 Financial risk management and financial HTML 54K
instruments - Credit risk (Details)
139: R132 Financial risk management and financial HTML 40K
instruments - Currency risk (Details)
140: R133 Commitments and contingencies - Minimum payments HTML 51K
payable over the next five years (Details)
141: R134 Segment reporting (Details) HTML 58K
142: R135 Segment reporting - Geographical information HTML 54K
(Details)
144: XML IDEA XML File -- Filing Summary XML 282K
143: EXCEL IDEA Workbook of Financial Reports XLSX 176K
2: EX-101.INS XBRL Instance -- apha-20190531 XML 8.42M
4: EX-101.CAL XBRL Calculations -- apha-20190531_cal XML 323K
5: EX-101.DEF XBRL Definitions -- apha-20190531_def XML 1.35M
6: EX-101.LAB XBRL Labels -- apha-20190531_lab XML 2.82M
7: EX-101.PRE XBRL Presentations -- apha-20190531_pre XML 2.09M
3: EX-101.SCH XBRL Schema -- apha-20190531 XSD 552K
145: ZIP XBRL Zipped Folder -- 0001279569-19-001826-xbrl Zip 407K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 40-F
(AMENDMENT NO. 1)
| ¨ | Registration statement pursuant to Section 12 of the Securities Exchange Act of 1934 |
or
| x | Annual report pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 |
| For the fiscal year ended May 31, 2019 | Commission File Number 001-38708 |
Aphria Inc.
(Exact name of Registrant as specified in its charter)
| Canada (Province or other jurisdiction of incorporation or organization) |
2833 (Primary Standard Industrial Classification Code Number) |
N/A (I.R.S. Employer Identification Number) |
265 Talbot St. W.
Leamington, Ontario, Canada N8H 4H3
(844) 427-4742
(Address and telephone number of Registrant’s principal executive offices)
|
CT Corporation
System (Name, address (including zip code) and telephone number (including area code) of agent for service in the United States) |
Securities registered or to be registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| Common Shares | APHA | New York Stock Exchange |
Securities registered pursuant to Section 12(g) of the Act: Common Shares, no par value
Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act: None
For annual reports, indicate by check mark the information filed with this Form:
| x Annual information form | x Audited annual financial statements |
Indicate the number of outstanding shares of each of the registrant’s classes of capital or common stock as of the close of the period covered by the annual report: 250,989,120
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports); and (2) has been subject to such filing requirements for the past 90 days. x Yes ¨ No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files). ¨ Yes ¨ No
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 12b-2 of the Exchange Act.
Emerging growth company x
If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards† provided pursuant to Section 13(a) of the Exchange Act. ¨
† The term “new or revised financial accounting standard” refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.
EXPLANATORY NOTE
Aphria Inc. (“Aphria” or the “Registrant”) is filing this Amendment No. 1 (the “Form 40-F/A”) to its Annual Report on Form 40-F for the year ended May 31, 2019 (the “Fiscal Year”), filed on August 1, 2019 (the “Original Filing”), solely to furnish its financial statements for the Fiscal Year formatted in eXtensible Business Reporting Language (“XBRL”). In accordance with the policy of the Securities and Exchange Commission (the “Commission”) stated in Release No. 33-9002, Aphria is filing this Form 40-F/A within the 30-day period available to first-time XBRL filers following the filing of our Form 40-F Annual Report, as filed with the Commission in the Original Filing.
C:
C: 2
SIGNATURES
Pursuant to the requirements of the Exchange Act, the Registrant certifies that it meets all of the requirements for filing on Form 40-F and has duly caused this Annual Report to be signed on its behalf by the undersigned, thereunto duly authorized.
| APHRIA INC. | |||
| By: | /s/ Irwin Simon . | ||
| Name: | Irwin Simon | ||
| Title: | Chief Executive Officer | ||
Date: August 23, 2019
C:
3
The following documents are being filed with the Commission as Exhibits to this Form 40-F/A:
| Exhibit | Description |
| 99.1 | Annual Information Form dated July 31, 2019* |
| 99.2 | Audited Annual Consolidated Financial Statements and notes thereto as at and for the years ended May 31, 2019 and May 31, 2018, together with the report thereon of the independent auditor* |
| 99.3 | Management’s Discussion and Analysis for the years ended May 31, 2019 and May 31, 2018* |
| 99.4 | Certificate of Chief Executive Officer Pursuant to Rule 13a-14(a) of the Exchange Act* |
| 99.5 | Certificate of Chief Financial Officer Pursuant to Rule 13a-14(a) of the Exchange Act* |
| 99.6 | Certificate of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002* |
| 99.7 | Certificate of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002* |
| 99.8 | Consent of PricewaterhouseCoopers LLP* |
| XBRL | |
| 101.INS | XBRL Instance |
| 101.SCH | XBRL Taxonomy Extension Schema |
| 101.CAL | XBRL Taxonomy Extension Calculation Linkbase |
| 101.DEF | XBRL Taxonomy Extension Definition Linkbase |
| 101.LAB | XBRL Taxonomy Extension Label Linkbase |
| 101.PRE | XBRL Taxonomy Extension Presentation Linkbase |
* Previously filed in the Original Filing.
C:
4
| This ‘40-F/A’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed as of: | 8/26/19 | |||
| Filed on: | 8/23/19 | 6-K, F-10, F-X | ||
| 8/1/19 | 40-F, 6-K | |||
| 7/31/19 | ||||
| For Period end: | 5/31/19 | 40-F | ||
| 5/31/18 | ||||
| 4/5/12 | ||||
| List all Filings | ||||